Emerging treatments of multiple myeloma; beyond IMIDs and bortezomib

The successful clinical development of thalidomide, bortezomib and lenalidomide not only transformed the therapeutic management of multiple myeloma (MM), but also catalyzed a renewed interest in the development of additional classes of novel agents for this disease. This review focuses on a series o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Mitsiades, Constantine S., Hideshima, Teru, Chauhan, Dharminder, McMillin, Douglas W., Klippel, Steffen, Laubach, Jacob P., Munshi, Nikhil C., Anderson, Kenneth C., Richardson, Paul G.
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2746942/
https://ncbi.nlm.nih.gov/pubmed/19389500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2009.02.003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares